Medicare Enrolled

Dr. Frank Melograna, M.D.

Urology Physician · Ormond Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
300 CLYDE MORRIS BLVD STE C, Ormond Beach, FL 32174
3866735100
In practice since 2005 (20 years)
NPI: 1528050895 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Melograna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melograna? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Melograna

Dr. Frank Melograna is an urology physician in Ormond Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Melograna performed 22,282 Medicare services across 2,868 unique beneficiaries.

Between the years covered by Open Payments, Dr. Melograna received a total of $7,298 from 41 pharmaceutical and/or device companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Melograna is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 5% volume in FL$ $7,298 industry payments

Medicare Practice Summary

Medicare Utilization ↗
22,282
Medicare services
Top 5% in FL for urology physician
2,868
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,114 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Testosterone injection16,830$0$0
Creatinine test (kidney function)1,074$5$25
Infectious disease DNA/RNA test650$34$86
Office visit, established patient (30-39 min)591$90$325
Urinalysis with microscopic exam578$3$10
Office visit, established patient (20-29 min)507$65$215
Automated urinalysis498$2$10
Bladder ultrasound after voiding322$7$200
New patient office visit (45-59 min)218$120$600
Yeast/candida DNA test148$34$81
Drug injection, under skin or into muscle128$11$75
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique122$68$83
Electronic assessment of bladder emptying113$10$275
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month93$47$405
Ct scan of abdomen and pelvis without contrast51$144$850
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique50$34$84
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique48$34$85
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique43$35$83
X-ray of abdomen, 1 view40$22$130
Injection, garamycin, gentamicin, up to 80 mg28$2$25
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month27$36$375
Insertion of device into abdomen with pressure and urine flow rate study21$147$555
Shock wave crushing of kidney stones19$425$3,040
Needle biopsy of prostate gland using image guidance18$292$800
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings16$27$600
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies13$283$1,000
Diagnostic exam of bladder and urethra using an endoscope12$185$470
Dilation of urethra using an endoscope12$253$1,470
New patient office visit (30-44 min)12$81$300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,298
Total received (2018-2024)
Avg $1,043/year across 7 years
Top 29% in FL for urology physician
41
Companies
211
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,106 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$192 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$295
2023
$768
2022
$1,833
2021
$1,040
2020
$634
2019
$2,061
2018
$667

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$2,293
NeoTract Inc.
$1,352
Astellas Pharma US Inc
$473
PFIZER INC.
$439
Teleflex LLC
$309
Sumitomo Pharma America, Inc.
$222
Axonics Modulation Technologies, Inc.
$207
Antares Pharma, Inc.
$189
Myovant Sciences Inc.
$168
Boston Scientific Corporation
$162
Endo Pharmaceuticals Inc.
$137
ABBVIE INC.
$137
Janssen Biotech, Inc.
$132
Zyla Life Sciences
$123
Dendreon Pharmaceuticals LLC
$112
Medtronic USA, Inc.
$99
AbbVie, Inc.
$93
Medtronic, Inc.
$91
BOSTON SCIENTIFIC CORPORATION
$55
Coloplast Corp
$47
Ferring Pharmaceuticals Inc.
$46
Avadel Specialty Pharmaceuticals, LLC
$42
Allergan Inc.
$37
Myriad Genetic Laboratories, Inc.
$33
Tolmar, Inc.
$27
TOLMAR Pharmaceuticals, Inc.
$27
Amgen Inc.
$25
Supernus Pharmaceuticals, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Wilmington Medical Supply, Inc.
$18
AbbVie Inc.
$18
MEDIVATION FIELD SOLUTIONS LLC
$17
Clarus Therapeutics Inc.
$17
Blue Earth Diagnostics Limited
$17
Acerus Pharmaceuticals Corporation
$15
Olympus America Inc.
$15
UroGen Pharma, Inc.
$14
Cook Medical LLC
$14
Janssen Pharmaceuticals, Inc
$12
Zyla Life Sciences, Inc.
$11
Aytu BioScience, Inc
$11
Top 3 companies account for 56.4% of total payments
Associated products mentioned in payments ›
ADVANTAGE FIT · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bulkamid · CONTINENCE CARE · Cook · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL ONCOLOGY · GREENLIGHT · INTERSTIM · JATENZO · JELMYTO · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Otrexup · PROLARIS · PROVENGE · Rezum Generator · SPACEOAR · SPEEDICATH · SPRIX · SpaceOAR VUE System - 10mL · TESTOPEL · TLANDO · TOVIAZ · UROLIFT · UroLift · UroLift System · XGEVA · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $33 per 100 Medicare services performed
Looking for a urology physician in Ormond Beach?
Compare urology physicians in the Ormond Beach area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
30
Per 100K population
5.3
County median income
$66,581
Nearest hospital
ADVENTHEALTH DAYTONA BEACH
6.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Melograna is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Melograna experienced with testosterone injection?
Based on Medicare claims data, Dr. Melograna performed 16,830 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Melograna receive payments from pharmaceutical companies?
Yes. Dr. Melograna received a total of $7,298 from 41 companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Melograna's costs compare to other urology physicians in Ormond Beach?
Dr. Melograna's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Melograna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →